Effectiveness of a five times daily triple therapy regimen against Helicobacter pylori.
Lynch
D A
DA
Centre for Digestive Diseases, General Infirmary at Leeds, UK.
Sobala
G M
GM
Gallacher
B
B
Dixon
M F
MF
Axon
A T
AT
D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000209:etiology; D005773:Gastroscopy; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori / Q000187:drug effects; D006801:Humans; D008795:Metronidazole / Q000494:pharmacology; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D010118:Oxytetracycline / Q000008:administration & dosage / Q000627:therapeutic use*; D011899:Ranitidine / Q000008:administration & dosage / Q000627:therapeutic use*
D000897:Anti-Ulcer Agents; D009942:Organometallic Compounds; D008795:Metronidazole; D011899:Ranitidine; C002791:bismuth tripotassium dicitrate; D010118:Oxytetracycline